Honolulu Star-Advertiser

Thursday, April 25, 2024 73° Today's Paper


Hawaii News

Cardax revenue sinks 47% in first quarter

Dave Segal
1/1
Swipe or click to see more

CRAIG T. KOJIMA / 2015

David Watumull, CEO of tech company, Cardax Pharmaceuticals Inc., in his laboratory. Cardax Inc.’s revenue plunged 47.3% in the first quarter as the health store chain selling its anti-inflammatory product ZanthoSyn worked through existing inventory and ramped up promotions.